Georgia's Online Cancer Information Center

Find A Clinical Trial

Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

Cancer Type
Hematopoietic Malignancies
Solid Tumor
Trial Phase
Phase I
0 Years and older, Male and Female
Study Type
Protocol IDs
208750 (primary)
Study Sponsor


This trial will evaluate long term safety of participants who have received GlaxoSmithKline
(GSK) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.


Participants who received a GSK adoptive cell therapy will be enrolled in this
non-therapeutic, multi-center, long term follow-up (LTFU) study and will be followed for up
to 15 years post-infusion of lentiviral vector-based adoptive cell therapy. Participants will
be monitored for safety following last adoptive cell therapy infusion.


  1. Participants who have received at least one dose of GSK adoptive cell therapy agent.
  2. Participants who have completed GSK sponsored or supported interventional study or have withdrawn from it.
  3. Participants who have completed treatment as part of managed access to a GSK adoptive cell therapy.
  4. Contraceptive use by men or women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.
  5. The investigator is responsible for review of medical history.
  6. Capable of giving signed informed consent.

Treatment Sites in Georgia

Winship Cancer Institute of Emory University

1365 Clifton Road NE
Building C
Atlanta, GA 30322

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.